. Primer sequence ························································ 13 Table 3 . Quantitation of mRNA Levels ································· 23 degrees of disc degeneration in human discs. Degenerated discs were obtained from 18 patients who underwent discectomy for lumbar disc herniation. Disc degeneration was graded by T2-weighted MRI using Pfirrmann's grading system. Discs were allocated to two groups; Group I (9 patients) -mildly degenerated discs (grades 2 and 3), and Group II (9 patients) -severely degenerated discs (grades 4 and 5). Cells from the nucleus pulposus were isolated and then cultured as monolayers.
The mRNA expressions of aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase, osteocalcin, TNF-α, and IL-1β in the two groups were compared by real-time PCR, and those of matrix associate proteins (aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase, osteocalcin) were compared by western blotting. mRNA expressions in Group I were upregulated versus Group II to the following extents; 1.83 times for aggrecan, 1.82 times for Type II collagen, 1.80 times for Sox9, 1.41 times for Type I collagen, 1.38 times for alkaline phosphatase, 1.80 times for osteocalcin, and.
Furthermore, western blotting showed that aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase, and osteocalcin were higher in Group I. However, the mRNA levels of TNF-α and IL-1β were 1.26 and 1.11-fold upregulated in Group II. Mildly degenerated discs showed greater matrix, chondrogenic, and osteoblastic gene expressions than severely degenerated discs, indicating that the ability to produce matrix-associated proteins is greater for cells in mildly degenerated than in severely degenerated discs. However, inflammatory cytokines genes associated with disc degeneration were expressed at higher levels in the severely degenerated group. This study shows that a reduction in matrix synthesis and an increase of inflammatory cytokine levels occurs during disc degeneration. The pathogenesis of intervertebral disc degeneration is a complex process that disrupts the well-defined organizational and biochemical balance due to the replacement of normal nucleus pulposus disc matrix by more fibrotic, less cartilaginous material. [1] [2] [3] [4] [5] Disc degenerative changes can be associated with pain, and treatment options for disc degeneration are limited. Many trials of potential molecular and biologic therapies have been conducted in this context.
Previous studies have evaluated three main biochemical changes; 1) decreased matrix synthesis, 2) increased catabolism, and 3) change in growth factors and cytokines associated with altered disc cell phenotypes during disc aging and degeneration.
1, 2, 6-9 Of the various genes associated with matrix synthesis, Type I and Type II collagens (fibrillar molecules), aggrecan (consists of a core protein to which sulfated-glycosaminoglycans), Sox-9 (which upregulates both aggrecan and Type II collagen), osteocalcin and alkaline phosphatase (markers of osteogenic genes), are important. 2, 7, 8, 10 And, of the cytokines associated with disc degeneration, the pro-inflammatory cytokines; tumor necrosis factor-α (TNF-α) and interleukin (IL) also play important roles. 6, [11] [12] [13] However, no study has investigated the expressions of genes associated with disc matrix synthesis and of cytokines associated with disc degradation with respect to disc degeneration in human discs at the same time.
This study was conducted to investigate the expressions of matrix associate genes and cytokine expressions in discs showing various degrees of degradation. The purpose of this study was to identify important factors of disc degeneration among genes involved in matrix synthesis and among proinflammatory cytokines, and to suggest a strategy for a molecular therapy.
II. MATERIALS AND METHODS
Clinical materials
Disc specimens obtained from 18 patients that underwent discectomy for lumbar disc herniation unresponsive to conservative therapy were utilized in the present study. Only nucleus pulposus samples were taken during surgery. After dissecting the disc space, the author made a rectangular cut around the annulus fibrosus with a sharp knife (Figure 1 ), and using a pituitary forceps, removed the disc with annulus and nucleus en block ( Figure   2A ). After confirming the margin of the annulus and nucleus, only the nucleus was excised for this study ( Figure 2B ). MRI (Magneton Vision 1.5T, Siemens, Erlangen, Germany) was performed on all patients. PACS software and a PACS workstation (Centricity 2.0, General Electrics Medical Systems, Milwaukee, WI) were used by an independent neurosurgeon and neuroradiologist not involved in treatment to disc degeneration. Disc degeneration was graded using routine T2-weighted MR images using Pfirrmann's grading system (Table 1 ). 14 Discs were classified into two groups.
Group I (9 patients) contained mildly degenerated discs (grades 2 and 3), and
Group II (9 patients) contained severely degenerated discs (Grades 4 and 5). All reagents were purchased from GibcoBRL (Grand Island, NY).
During lumbar discectomy, intervertebral disc materials were excised, and as mentioned above to ensure sample homogeneity, disc tissues were acquired from the nucleus pulposus not from the annulus. Tissues were dissected into small pieces and incubated in 5% CO 2 /95% room air at genes examined in this study are summarized in Table 2 . 
Western blot analysis
We also compared matrix associated protein synthesis (aggrecan, to allow proteins to be detected.
Statistical analysis
Intergroup comparisons were analyzed using Wilcoxon's Signed Rank test. P values of less than 0.05 were considered statistically significant.
All analyses were carried out using SPSS Ver. 12.00K (SPSS, Inc., Chicago, IL).
III. RESULTS
Patient Characteristics
The discs of 18 patients were classified into two Groups. Group I (9 patients) contained mildly degenerated discs (Grade 2, 5 patients; Grade 3, 4 patients), and Group II (9 patients) contained severely degenerated discs (Grade 4, 7 patients; Grade 5, 2 patients). Mean patient age in Group II (56.9±13.9 years) was significantly higher than in Group 1 (43.1±13.3years) (P<0.05).
Quantitation of mRNA Levels
We assayed the mRNA levels of genes specific for aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase, osteocalcin, TNF-α, and IL-1β. mRNA gene expression in Group I (mildly degenerated discs) was significantly greater for aggrecan (1.83-fold*), Type II collagen (1.82-fold*), Sox9 (1.80-fold*), Type I collagen (1.41-fold*), alkaline phosphatase (1.38-fold*), and osteocalcin (1.80-fold**) ( Table 3 ) (Fig 4) . However, mRNA levels of TNF-α (1.26-fold*) and IL-1β (1.11-fold*) were significantly greater in Group II (Table 3 ) (Fig. 4 ) (* indicates P<0.01 and ** indicates P<0.05). 
Expression by Western blot assay
When we investigated the matrix associate proteins (aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase and osteocalcin) levels by Western blotting, Group I was found to express higher protein levels than Group II ( Figure 5 ). 
IV. DISCUSSION
The integrity of intervertebral discs is dependent on the balance between matrix synthesis and degradation. During aging or when affected by disease, disc cells undergo substantial degenerative changes, which including cell type and cell phenotype alterations, the latter of which is characterized by a compromised ability to synthesize normal matrix components and by enhanced catabolism. 4, 6, 15 Previous studies evaluated three types of biochemical change caused by an altered disc cell phenotype during disc aging and degeneration 1, 4, 6, 11, 15 , namely, a decrease in matrix synthesis, increased catabolism, and changes in growth factors and cytokines. 2, [6] [7] [8] In the present study, we sought to determine which of these types of biochemical change is initially responsible for disc degeneration. Previous studies have
shown that various genes (aggrecan, Type II collagen, Sox9, Type I collagen, alkaline phosphatase, osteocalcin, and others) are downregulated in degenerated discs. 4, 6, 10, 15 Of the various genes associated with matrix synthesis, Type I and Type II collagens act as fibrillar molecules, aggrecan consists of a core protein to which sulfated-glycosaminoglycans, Sox-9
upregulates both aggrecan and Type II collagen, osteocalcin and alkaline phosphatase are markers of osteogenic genes. 2, 7, 8, 10 Here, we investigated above genes that have been most strongly associated with matrix synthesis.
Furthermore, it is also known that various pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-1α, nitro oxide, prostaglandin E 2 , and others) are upregulated during disc degeneration. 1, 6, 9, 16, 17 Of these cytokines, TNF-α and IL-1β are well known to be associated with disc degradation and discogenic back pain. [18] [19] [20] TNF-α is an important initiator of matrix degeneration, whereas IL-1β plays a greater role in pathological degradation. 12 Accordingly, we focused on these cytokines.
Molecular therapies for disc degeneration have been devised based on phenotype changes in degenerated discs. 1 Four different classes of molecules are currently being investigated in this context, namely, anticatabolics, mitogens, morphogens, and intracellular regulators. 1, 3, 8, 13, 16, [20] [21] [22] However, molecular therapy trials conducted to date have been conducted on individual candidates. 1, 3, 8, 13, 16, [20] [21] [22] This is the first study to evaluate both disc matrix synthesizing factors and cytokines associated with disc degeneration in human discs with respect to the extent of disc degeneration. The present study
shows that the genes of matrix factors are downregulated but that those of pro-inflammatory cytokines are simultaneously upregulated during disc degeneration. These results concur with those of a previous study. 1, 4, 6, 10, 11, 15, 16 Our western blotting results also show that matrix associated protein levels reduced in accord with degree of disc degeneration.
From this study, we had some clue for disc degeneration. Initially we were interested in answering the question "Which of the three types of biologic changes is primarily responsible for the initiation of disc degeneration?" The answer appears to be that these changes co-occur. This indicates that current strategies for molecular therapies should be modified. A number of molecules have been studied in vitro and in vivo in this context with encouraging results. 1, 3, 8, 9, 16, 20, 22, 23 However, previous trials have focused on single candidates, whereas our results indicate that a molecular therapy should address all factors associated with disc degeneration simultaneously.
This study has several limitations that require consideration. First, the sample size was too small to examine in detail relations between matrix and cytokine components and disc degeneration at different levels. In addition, to determine the mechanism of disc degeneration, longitudinal studies are required to identify the major factors responsible for disc degeneration, such as, reduced matrix synthesis, increased catabolism, and expressional changes of growth factors and inflammatory cytokines. Furthermore, these studies should include a range of disc degenerations from normal to most severe. In addition, the findings of the present suggest that future molecular therapies should be composite therapies that address all factors associated disc degeneration.
V. CONCLUSION
Our results show that mildly degenerated disc cells more potently express matrix, chondrogenic, and osteoblastic genes than severely degenerated disc cells. In addition, it shows that catabolic cytokines associated with disc degeneration were more highly expressed in severely degenerated discs. Furthermore, decreases in matrix synthesis, increase of inflammatory cytokine levels were found to occur simultaneously during disc 
